These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11397368)

  • 1. Effect of quinapril versus nitrendipine on endothelial dysfunction in patients with systemic hypertension.
    Uehata A; Takase B; Nishioka T; Kitamura K; Akima T; Kurita A; Isojima K
    Am J Cardiol; 2001 Jun; 87(12):1414-6. PubMed ID: 11397368
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of cerebrovascular reactivity by methionine-induced hyperhomocysteinemia and amelioration by quinapril treatment.
    Chao CL; Lee YT
    Stroke; 2000 Dec; 31(12):2907-11. PubMed ID: 11108747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension.
    Korkmaz H; Karaca I; Koç M; Onalan O; Yilmaz M; Bilen MN
    Endothelium; 2008; 15(3):149-55. PubMed ID: 18568956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Wargovich TJ; O'Neill B; Mancini GB; Haber HE; Pitt B; Pepine CJ
    Am J Cardiol; 1997 Dec; 80(12):1594-7. PubMed ID: 9416943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y; Lefebvre J; Provencher P; Poirier L
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
    Larochelle P
    Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
    Schnaper HW
    Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension.
    Huang JL; Cheng FC; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinapril improves endothelial function in postmenopausal hypertensive patients.
    Farkas K; Fábián E; Nagy L
    Kidney Blood Press Res; 2008; 31(4):226-33. PubMed ID: 18587241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pörsti I
    Br J Pharmacol; 1995 Jul; 115(5):859-67. PubMed ID: 8548188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.